Summary - A new market study, titled “Global Organ-On-Chips Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030” has been featured on WiseGuyReports.

Market Overview
Global Organ-on-a-Chip market grew at USD XX million in 2019 and is expected to grow at a CAGR of XX% in the forecasted period. Increase in animal testing, research funding, capital investments, new product launches and rise in technological investments is likely to increase the growth of the market.
Global Organ-on-Chips Market: Segments
Global Organ-on-Chips Market can be segmented on the basis of type, application, end-user and regions.
ALSO READ: https://www.marketwatch.com/press-release/global-organ-on-chips-mar...
By organ type (in %), global organ on chips Market, 2019
Liver segment dominated the market with a total revenue of USD 3.62 million in 2019
By organ type it can be categorized into liver, heart, lungs and others.
The liver segment shows significant growth due to the increased liver related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.
Global Organ-on-Chips Market: Drivers and Restraints
Drivers
• Worldwide demand for OOCs
OOCs now are being studied worldwide as instruments to develop disease models and to predict drug efficacy and toxicity accurately. Many companies and universities constantly seek new and better models for the development of drugs. OOCs benefit from cell growth, animal models and human clinically focused diagnosis have caught the interest of medical and pharmaceutical communities which are focusing on developing targeted therapies.
Restraint
• High costs
For drug discovery and growth, OOCs are considered more important and reliable than animal patterns and cell cultures. Nonetheless, these chips cost a lot and redesigning step to suit mass production are high. High manufacturing costs restrict OOC's business growth as the relatively small businesses involved may be burdened by a costly redesign process.
Global Organ-on-Chips Market: Regions
region segment can be further divided into five major types including North America, Latin America, Europe, APAC and MENA.
North America holds the largest share in organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world class research institutes and pharmaceutical and biotechnology industries in the region. Though, APAC region is expected to become the fastest growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.
ALSO READ: http://www.marketwatch.com/story/artificial-lens-market-2020-global...
Global Organ-on-Chips Market: Key players
• Mimetas
o Business Strategy
o Key Product offerings
o Financial performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Hurel Corporation
• AxoSim
• Insphero AG
• MIMETAS BV
• Emulate
• InSphero
• Ascendance Bio
• Nortis
• Organovo Holdings, Inc.
ALSO READ: http://www.marketwatch.com/story/mobile-satellite-service-market-gl...
The Global Organ-on-Chips Market report also contains analysis on:
Global Organ-on-Chips
• Market segments: -
o By type:
 Liver
 Lungs
 Heart
 others
o By application:
 Drug discovery
 Toxicology research
 Other applications
o By end-user:
 Pharmaceutical and biotechnology companies
 academic and research institutes
 others
• Global Organ-on-Chips Market dynamics
• Global Organ-on-Chips Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints
FOR MORE DETAILS : https://www.wiseguyreports.com/reports/5686925-global-organ-on-chip...
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:
NORAH TRENT
[email protected]
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)